December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Five articles suggested by Yüksel Ürün
Oct 28, 2024, 08:58

Five articles suggested by Yüksel Ürün

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.

He suggested following few must-read papers on X:

1. “Trastuzumab deruxtecan (T-DXd) + Nivolumab shows promising antitumor activity in HER2-expressing metastatic breast & urothelial cancers. Key risk: ILD/pneumonitis.

Close monitoring essential.”

Trastuzumab Deruxtecan With Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study 

Authors: Erika Hamilton, Matthew D. Galsky, Sebastian Ochsenreither, Gianluca Del Conte, Miguel Martín, Maria José. de Miguel, Evan Y. Yu, Anja Williams, Maria Gion, Antoinette R. Tan, Laila Agrawal, Annemie Rutten, Jean-Pascal Machiels, Sara Cresta, Philip R. Debruyne, Audrey Hennequin, Victor Moreno, Anna Minchom, Frances Valdes-Albini, Daniel Petrylak, Li Li, Zenta Tsuchihashi, Fumitaka Suto , Fu-Chih Cheng, Maha Kandil, Daniel Barrios and Sara Hurvitz.

Yüksel Ürün

 

2. “Clinically critical Q. Twice-daily prednisone (2*5 mg) significantly reduces the risk of hypertension and hypokalemia in abiraterone-treated prostate cancer patients, without impacting BMI or blood sugar.”

Effect of Prednisone Dosing on Mineralocorticoid-Related Side Effects With Abiraterone in Prostate Cancer

AuthorsMaksym Goryachok, Andrew Nicklawsky, Hiba Ahmad, Christopher Geiger, Simon Kim and Thomas W. Flaig. 

Yüksel Ürün

3. “Antibody-drug conjugates (ADCs) are transforming cancer treatment with 11 FDA-approved and over 210 in trials. Despite successes, challenges remain in predicting activity, optimizing sequencing, and minimizing toxicity.”

The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development

Authors: Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, Patricia M. LoRusso and Elisabeth G.E. de Vries.

Yüksel Ürün

 

4. “Improving physician well-being is essential for healthcare. Organizations must reduce workload, offer confidential mental health support, and ensure diversity. ”

Burnout, Depression, and Diminished Well-Being among Physicians

Authors: Constance Guille and Srijan Sen.

Yüksel Ürün

5. “Aspartame consumption shows no association with breast cancer risk according to the Nurses’ Health Studies.”

Consumption of aspartame and risk of breast cancer in the Nurses’ Health Studies

Authors: Andrea Romanos-Nanclares, Eva Schernhammer, Walter C Willett, Michelle D Holmes, Y Chen and A Heather Eliassen.

Yüksel Ürün

For latest updates, follow OncoDaily